First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

H. Gelderblom, J. A. Gietema, I. M. E. Desar, N. M. Ajmone, M. Jalving, J. R. Kroep, V. Nicolas, A. Vaslin, K. Tobal, D. Purcea, S. F. van Haren, L. Damstrup

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S501-S502
Number of pages2
JournalAnnals of Oncology
Publication statusPublished - Sep-2020
EventESMO Virtual Congress -
Duration: 19-Sep-202018-Oct-2020

Cite this